Influences of Female Sex and Reproductive Hormones on Physiological Aspects of Heat Acclimation
1 other identifier
interventional
27
1 country
1
Brief Summary
Women are often understudied in thermal physiology research, leaving recommendations for Soldier safety and performance in hot conditions based largely on data collected in men. Female sex hormones estradiol and progesterone clearly have non-reproductive physiological effects, including influences on thermoregulatory and cardiovascular function. However, mechanisms of differing physiological adaptations to repeated heat exposure (i.e., heat acclimation) as a function of reproductive hormone status have yet to be investigated in a systematic way. Understanding possible sex differences in adaptation or mechanisms for adaptation during heat acclimation is important to ultimately optimize interventions to maximize soldier health and safety during training and deployment in the heat. Our goals in the present study are to evaluate physiological and biophysical responses to a standard heat acclimation protocol in a group of young, healthy men and women. Thirty individuals (n=10 males, n=10 women with a low hormonal status (i.e. early follicular phase), n=10 women with a high hormonal status (i.e. midluteal phase)) will complete 10 consecutive days of exercise (treadmill walking: 3.1 mph/2% grade) in the heat (40°C /40% relative humidity) up to 3hr per day. Changes in core temperature, heart rate, and sex hormones will be assessed to examine differences in thermoregulatory response to heat acclimation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2021
CompletedFirst Submitted
Initial submission to the registry
March 14, 2022
CompletedFirst Posted
Study publicly available on registry
March 23, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2024
CompletedAugust 7, 2024
August 1, 2024
2.6 years
March 14, 2022
August 5, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Core temperature
10 days
Heart rate
10 days
Study Arms (3)
Males
EXPERIMENTAL10 consecutive day heat acclimation in males
Females + high hormones
EXPERIMENTAL10 consecutive day heat acclimation in females with high hormonal dose
Females + low hormones
EXPERIMENTAL10 consecutive day heat acclimation in females with low hormonal dose
Interventions
10 consecutive days of heat acclimation
Eligibility Criteria
You may qualify if:
- Males and females, age 18-40 y (17 y for active duty military)
- Eumenorrheic females (menstrual cycle length between 24-35 days) or females taking oral contraceptives
- In good health as determined by OMSO (Office of Medical Support and Oversight) General Medical Clearance and willing to report all medications and dietary supplements (i.e. cold medication, Tylenol. Aleve) to the PI and OMSO.
- Passed his/her most recent Army Combat Fitness Test (ACFT) (military volunteers only) or exercise at least 2 times per week (civilian volunteers)
- Willing to not exercise, or drink alcoholic beverages for 24 hours before each testing session
- Willing to not consume caffeine 12 hours prior to any testing sessions
- Willing to refrain from additional moderate to strenuous physical activity throughout testing period
- Males and females with BMI \<30
You may not qualify if:
- Females who are pregnant or planning to become pregnant during the study
- Females utilizing implantable contraception (intrauterine device, implantable bar)
- Tested positive for COVID-19 within the past 30 days.
- Taking prescription or over the counter medication, other than a contraceptive (unless approved by OMSO and Principal Investigator (PI))
- Tobacco users, or anyone who has used tobacco within the last four months
- Physical problems/injuries that would affect walking or running on a treadmill
- Allergy to skin adhesive
- Heart, lung, kidney, muscle, endocrine, or nerve disorder(s)
- History of heat intolerance or orthostatic intolerance
- Diagnosed and/or treated for fluid/electrolyte imbalance within the last 30 days
- History of obstructive disease of the gastrointestinal tract including (but not limited to) diverticulosis, diverticulitis and inflammatory bowel disease, peptic ulcer disease, Crohn's disease, ulcerative colitis.
- Scheduled MRI during testing
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
U.S. Army Research Institute of Environmental Medicine
Natick, Massachusetts, 01760, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 14, 2022
First Posted
March 23, 2022
Study Start
October 1, 2021
Primary Completion
April 30, 2024
Study Completion
April 30, 2024
Last Updated
August 7, 2024
Record last verified: 2024-08